Comparing amiodarone doses for paroxysmal AF
Part of Heart & circulation clinical trials.
This study compares three different daily doses of the heart rhythm medication amiodarone to find the most effective one for preventing episodes of paroxysmal atrial fibrillation. Participants will take one of three doses (100, 200, or 400 mg) for up to 12 months, and the study will monitor how well each dose controls the irregular heartbeat.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old.
- You need to have a confirmed diagnosis of paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes).
- Your doctor must consider amiodarone a good treatment option for you.
- You cannot have certain other heart conditions, such as severe coronary artery disease needing urgent treatment, or blood clots in the heart.
- You must not be taking specific other medications (like some antidepressants, antibiotics, or heart rhythm drugs).
- You cannot be pregnant or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine, budiodarone, to help control atrial fibrillation (an irregular heartbeat) in people who haven't been helped by other treatments. It may reduce the time spent in AF and improve symptoms.
This trial tests two different ways of taking amiodarone (a heart rhythm medicine) to keep your heart in a normal rhythm after a procedure called electrical cardioversion. It's designed for people with persistent atrial fibrillation (a fast, irregular heartbeat lasting at least 7 days).
This study tests whether giving the medicine amiodarone before a scheduled electrical cardioversion (a procedure that shocks the heart back into rhythm) improves the chances of restoring a normal heartbeat in people with persistent atrial fibrillation. It compares outcomes with and without this pre-treatment.
This study tests whether giving a short course of a medication called amiodarone after heart surgery helps prevent or control new irregular heartbeats (atrial fibrillation) and helps you leave the hospital sooner.
This study tests a stepwise treatment plan for people with persistent atrial fibrillation (a long-lasting irregular heartbeat) who also have an enlarged left atrium. It aims to see if a medication called amiodarone plus a cardioversion procedure can help restore normal rhythm.
This study tests whether giving amiodarone both through an IV and as a pill, compared to just the pill, can better prevent atrial fibrillation from coming back after your first catheter ablation. The goal is to help you stay in a normal heart rhythm for longer.
Hear when a new Paroxysmal AF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.